Cargando…

Hepatitis B Surface Antibody (Anti-HBs) Kinetics during Rituximab Chemotherapy and Performance of Hepatitis B Vaccine before Immunosuppression: Two Prospective Studies

Rituximab promotes strong immunosuppression leading to a high risk of hepatitis B reactivation (HBV-R) and chronic infection. Current recommendations on HBV-R prevention are expensive and poorly individualized. In resolved hepatitis B patients, previous studies suggest that anti-HBs titers before im...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Araujo-Neto, João Marcello, Guimarães, Gabriela Sousa, Fernandes, Flavia Ferreira, Soares, Marcelo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415137/ https://www.ncbi.nlm.nih.gov/pubmed/36016402 http://dx.doi.org/10.3390/v14081780

Ejemplares similares

Hepatitis B Surface Antigen (HBsAg) Kinetics in Chronic Hepatitis B Patients during Peginterferon Treatment
por: Wang, Kaifa, et al.
Publicado: (2020)

Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B
por: Seto, Wai-Kay, et al.
Publicado: (2012)

Improving testing for hepatitis B before treatment with rituximab
por: Dyson, Jessica K., et al.
Publicado: (2016)

Evaluation of HBsAg Seroclearance in Patients with Hepatitis B
por: Taşkın, Mehmet Can, et al.
Publicado: (2022)

Moderate Risk of Hepatitis B Virus Reactivation in HBsAg(−)/HBcAb(+) Carriers Receiving Rituximab for Rheumatoid Arthritis
por: Kuo, Meng Hsuan, et al.
Publicado: (2020)

Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximab
por: Yoo, Dae San, et al.
Publicado: (2020)

Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs
por: Liu, Yong, et al.
Publicado: (2016)

Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen
por: Washizaki, Ayaka, et al.
Publicado: (2022)

Prediction for HBsAg seroconversion in children with chronic hepatitis B
por: Zhong, Yan-Wei, et al.
Publicado: (2021)

Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBV
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

Complete hepatitis B virus genome analysis in HBsAg positive mothers and their infants with fulminant hepatitis B
por: Friedt, Michael, et al.
Publicado: (2004)

Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)
por: Kaur, Satinder P., et al.
Publicado: (2022)

Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss
por: Wu, I-Chin, et al.
Publicado: (2021)

Clinical Implications of HBsAg Quantification in Patients with Chronic Hepatitis B
por: Viganò, Mauro, et al.
Publicado: (2012)

Evaluation of Chronic Hepatitis B Infection in Patients with Seronegative HbsAg
por: Parizad, E Gholami, et al.
Publicado: (2012)

Is occult Hepatitis B virus infection with detectable anti-HBs infectious or not?
por: Afyon, Murat, et al.
Publicado: (2016)

T-Cell Receptor β Chain and B-Cell Receptor Repertoires in Chronic Hepatitis B Patients with Coexisting HBsAg and Anti-HBs
por: Zhan, Qiao, et al.
Publicado: (2022)

Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination
por: Galati, Giovanni, et al.
Publicado: (2014)

Long-term outcomes of HBsAg/anti-HBs double-positive versus HBsAg single-positive patients with chronic hepatitis B
por: Kwak, Min-Sun, et al.
Publicado: (2019)

PgRNA kinetics predict HBsAg reduction in pregnant chronic hepatitis B carriers after treatment cessation
por: Wang, Chun-Rui, et al.
Publicado: (2022)

Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review
por: Cholongitas, Evangelos, et al.
Publicado: (2018)

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
por: Yin, Shengxia, et al.
Publicado: (2023)

Occult Hepatitis B Virus Infection in Anti-HBs-Positive Infants Born to HBsAg-Positive Mothers in China
por: Su, Haixia, et al.
Publicado: (2013)

Immunosuppression in Patients with Chronic Hepatitis B
por: Seetharam, Anil, et al.
Publicado: (2014)

Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors
por: Karimi, Gharib, et al.
Publicado: (2016)

Sequence Variations of Full-Length Hepatitis B Virus Genomes in Chinese Patients with HBsAg-Negative Hepatitis B Infection
por: Huang, Fung-Yu, et al.
Publicado: (2014)

Prevalence of Hepatitis B virus genotypes in HBsAg positive individuals of Afghanistan
por: Attaullah, Sobia, et al.
Publicado: (2011)

Reactivation of Hepatitis B Virus in HBsAg-Negative Patients with Hepatocellular Carcinoma
por: Jang, Jeong Won, et al.
Publicado: (2015)

HBsAg level and hepatitis B viral load correlation with focus on pregnancy
por: Belopolskaya, Maria, et al.
Publicado: (2015)

HBS Ag seroclearance and seroconversion time in Patients with chronic hepatitis B Infection
por: Masrour-Roudsari, Jila, et al.
Publicado: (2020)

Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infection
por: Yan, Ying, et al.
Publicado: (2022)

Mutations in the S gene and in the overlapping reverse transcriptase region in chronic hepatitis B Chinese patients with coexistence of HBsAg and anti-HBs
por: Ding, Feng, et al.
Publicado: (2015)

Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C
por: Ryu, Ji Hyeong, et al.
Publicado: (2018)

Protective Effect of Hepatitis B Vaccine Combined with Two-Dose Hepatitis B Immunoglobulin on Infants Born to HBsAg-Positive Mothers
por: Zou, Huaibin, et al.
Publicado: (2011)

Hepatitis B virus vaccination of voluntary blood donors and immunization status assessment by Anti-Hepatitis B Surface (HBs) antibody titer
por: Singh, R. P., et al.
Publicado: (2013)

Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant?
por: Brancaccio, Giuseppina, et al.
Publicado: (2020)

Late Hepatitis B reactivation after treatment with rituximab
por: Pereira, Sara Lacerda, et al.
Publicado: (2022)

Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
por: Chen, Kai-Lin, et al.
Publicado: (2015)

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas
por: Lan, Ting-Yuan, et al.
Publicado: (2023)

Molecular Epidemiology and Genotyping of Hepatitis B Virus of HBsAg-Positive Patients in Oman
por: Al Baqlani, Said Ali, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_togpp8g4epl0to582i0mj8sr9m